-
Sector Analysis
Contract Manufacturing Service Agreements – Rising Manufacturing Opportunities Driven by Pharmaceutical Pipeline Expansion
This report is a brand new publication covering contract service agreements, across a range of different services and manufacturing scales. The number of contract service agreements secured serves as a primary indicator of a CMO's performance. Contract Manufacturing Service Agreements is critical for establishing an understanding of the overall CMO industry, the range of services provided and the features of some of the largest CMOs participating in the industry.
-
Sector Analysis
Acne Vulgaris – Opportunity Analysis and Forecasts to 2026
Acne vulgaris (acne) is currently one of the most common and well-established dermatology conditions, affecting around 90% of the world’s population at some point in their lifetime. The disease is a chronic, inflammatory dermatological condition of the pilosebaceous gland of the skin with a multifactorial pathogenesis. It is usually initiated during puberty by hormonal changes and further exacerbated by genetic factors. Acne is a polygenic and multifactorial disease. According to current literature, the four major factors that interact with each...
-
Product Insights
Impetigo Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Impetigo Global Clinical Trials Review, H2, 2017" provides an overview of Impetigo clinical trials scenario. This report provides top line data relating to the clinical trials on Impetigo. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Telangiectasis Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Telangiectasis Global Clinical Trials Review, H2, 2018" provides an overview of Telangiectasis clinical trials scenario. This report provides top line data relating to the clinical trials on Telangiectasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Rosacea Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Rosacea Global Clinical Trials Review, H2, 2018" provides an overview of Rosacea clinical trials scenario. This report provides top line data relating to the clinical trials on Rosacea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Scabies Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Scabies Global Clinical Trials Review, H2, 2018" provides an overview of Scabies clinical trials scenario. This report provides top line data relating to the clinical trials on Scabies. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Impetigo Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Impetigo Global Clinical Trials Review, H2, 2016" provides an overview of Impetigo clinical trials scenario. This report provides top line data relating to the clinical trials on Impetigo. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Rosacea Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Rosacea Global Clinical Trials Review, H2, 2016" provides an overview of Rosacea clinical trials scenario. This report provides top line data relating to the clinical trials on Rosacea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Rosacea Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Rosacea Global Clinical Trials Review, H1, 2016" provides an overview of Rosacea clinical trials scenario. This report provides top line data relating to the clinical trials on Rosacea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Impetigo Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Impetigo Global Clinical Trials Review, H1, 2016" provides an overview of Impetigo clinical trials scenario. This report provides top line data relating to the clinical trials on Impetigo. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...